First Citizens Wealth today announced the appointment of Erin McCaskill as Director and Atlanta Market Leader. Based in Atlanta, she reports to Ethan Van Eck, Senior Director of Regional Wealth, and will lead a First Citizens team of wealth consultants. https://mma.prnewswire.com/media/2806022/First_Citizens_Bank_Erin_McCaskill.jpg McCaskill is responsible for growing a high-caliber team serving the needs of high-net-worth individuals […]

NetworkNewsWire Editorial Coverage The global cancer-therapy landscape is undergoing a rapid evolution toward precision drug-delivery systems designed to boost efficacy, limit toxicity and elevate patient outcomes. Conventional oral and intravenous treatments continue to face significant challenges, chief among them lowbioavailability and inadequate tumor targeting. These factors often limit the success of these treatments in clinical

NetworkNewsWire Editorial Coverage The rapid ascent of artificial intelligence (AI) isn't being slowed by a lack of computing power, it's being constrained by electricity. As AI expands globally, data centers are consuming energy at an unprecedented rate, outpacing what utilities can deliver, overloading aging grids and driving up costs for consumers. The result is a

HiBob, the company behind Bob, the people management platform transforming how organizations work in the age of AI, today announced the launch of In Good Company, a global community for people-first leaders reimagining how work should work for everyone. The community brings together HR professionals, people managers, and emerging leaders who believe that putting employees

SALT LAKE CITY, Oct. 29, 2025 (GLOBE NEWSWIRE) — PolarityBio, a clinical-stage biotechnology company focused on addressing unmet needs in wound healing through innovation in autologous regenerative skin multicellular therapy, today announced that the American Medical Association (AMA) CPT(R) Editorial Panel has accepted the company's Category III CPT(R) Code Application for its Autologous Heterogeneous Skin

Acquisition increases power under contract by 28% 271-acre site is positioned on a major fiber backbone with 285 MW of power to anchor CleanSpark's expansion into high-performance compute and AI infrastructure CleanSpark, Inc. (Nasdaq: CLSK), America's Bitcoin Miner® (“CleanSpark” or the “Company”), announced today it has acquired the rights to approximately 271 acres of land

Direct Digital Holdings, Inc. (Nasdaq: DRCT) (“Direct Digital Holdings” or the “Company”), a leading advertising and marketing technology platform operating through its companies Colossus Media, LLC (“Colossus SSP”) and Orange 142, LLC (“Orange 142”), today announced that the Company will report financial results for the third quarter ended September 30, 2025 on Thursday, November 6,

CNA authorization empowers Foxit to assign official CVE IDs, advancing transparency and efficiency in vulnerability disclosure Foxit, a global leader in PDF and document productivity solutions, today announced that it has been authorized as a CVE Numbering Authority (CNA) by the Common Vulnerabilities and Exposures (CVE) Program. https://mma.prnewswire.com/media/2620217/new_foxit_Logo_2025.jpg This designation officially authorizes Foxit to assign

Caris Life Sciences®(NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, announced collaborative new research identifying TET2 clonal hematopoiesis (CH) as a promising biomarker for improved response to immune checkpoint inhibitor (ICI) therapy in patients with solid tumors.The study titled, `TET2-mutant clonal hematopoiesis enhances macrophage antigen presentation and improves immune checkpoint

PolarityBio Announces Acceptance of Category III CPT(R) Code Application for Autologous Heterogeneous Skin Construct Graft by AMA CPT(R) Editorial Panel Secured Category III CPT Codes Pave the Way for Broader Access to Regenerative Skin Construct GlobeNewswire October 29, 2025 SALT LAKE CITY, Oct. 29, 2025 (GLOBE NEWSWIRE) — PolarityBio, a clinical-stage biotechnology company focused on